The ASCO Annual Meeting is one of the world’s leading oncology congresses, bringing together international experts to discuss the latest advances in cancer research and patient care.
The Biocodex Microbiota Institute will participate through a dedicated CME activation focused on oncology and microbiota, highlighting the growing role of the microbiome in cancer treatment, immunotherapy response, and supportive care.
